New User Account Set Up

If you do not have an account with the Digest, please click on "Submit to the Digest." By logging in with your UCLA Login ID (formerly known as BOL Login), a new account will automatically be generated. If you experience any difficulties, please send an email to our help desk: drcsupport@mednet.ucla.edu.

Questions

If you have any questions or concerns, please email our help desk/support team: drcsupport@mednet.ucla.edu. We are more than happy to address any questions or concerns regarding the Weekly Message Digest system you may have.

How do I subscribe?

If you have a mednet email account (@mednet.ucla.edu), you should already be subscribed.

If you do not have a mednet email account or you are not receiving the Digest, please send an email to drcsupport@mednet.ucla.edu and we will add you to our list.

Simms/Mann: "Hematologic Cancers – Diagnosis and Treatment in 2019" - Herbert Eradat, MD

DGSOM WMD twitter logo

Title: Simms/Mann: "Hematologic Cancers – Diagnosis and Treatment in 2019" - Herbert Eradat, MD
Date & Time: Aug 13, 2019 7:00 PM - 9:00 PM
Location: B130 RRMC

 

Hematologic Cancers – Diagnosis and Treatment in 2019 - Herbert Eradat, MD, Clinical Associate Professor, Department of Hematology/Oncology, member of the JCCC Signal Transduction and Therapeutics Program, discusses the different types of hematologic cancers including leukemias and lymphomas, standard treatment approaches, and the expanding novel therapeutics for these diseases. Research is rapidly evolving as we learn more about the biology of each type of leukemia and lymphoma and Dr. Eradat will highlight several new, exciting therapies currently in clinical trials.

Posting Information
This posting expired on August 14, 2019.

Share this posting on social media!